Article Information
History
- January 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zhenxiao Ren1,
- Mitsuhiro Nishimura, PhD1,†,
- Lidya Handayani Tjan, MD, PhD1,
- Koichi Furukawa, MD1,
- Yukiya Kurahashi, MD1,
- Silvia Sutandhio, MD1,
- Kaito Aoki1,
- Natsumi Hasegawa1,
- Jun Arii, DVM, PhD1,
- Kenichi Uto2,
- Keiji Matsui, PhD2,
- Itsuko Sato2,
- Jun Saegusa, MD, PhD2,
- Nonoka Godai3,4,
- Kohei Takeshita, PhD4,
- Masaki Yamamoto, PhD3,4,
- Tatsuya Nagashima, MD, PhD5 and
- Yasuko Mori, MD, PhD1,*
- 1Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
- 2Department of Clinical Laboratory, Kobe University Hospital, Kobe, Hyogo, Japan
- 3Laboratory of Macromolecular Dynamics and X-ray Crystallography, Department of Life Science, University of Hyogo, Hyogo, Japan
- 4Life Science Research Infrastructure Group, Advanced Photon Technology Division, RIKEN SPring-8 Center, Hyogo, Japan
- 5Hyogo Prefecture Health Promotion Association, Kobe, Hyogo, Japan
- ↵*Corresponding author:
Prof. Yasuko Mori, Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan. Email: ymori{at}med.kobe-u.ac.jp, Tel: +81-78-382-6272 Fax: +81-78-382-6879 - ↵†Alternate author:
Dr. Mitsuhiro Nishimura, Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan. Email: mnishimu{at}med.kobe-u.ac.jp, Tel: +81-78-382-6272 Fax: +81-78-382-6879
Posted January 13, 2022.
Large-scale cross-sectional seroepidemiologic study of COVID-19 in Japan: Acquisition of herd immunity and the vaccines’ efficacy
